Annexon Outlines 2024 Priorities with Late-Stage Clinical Mi

ANX005 Phase 3 Pivotal Data in Guillain-Barré Syndrome (GBS) On Track for First Half of 2024; Potential to be First Approved Treatment for GBS Patients in the…

Related Keywords

, Global Pivotal Program In Geographic Atrophy , First Half , First Approved Treatment , Pivotal Program , Geographic Atrophy , Pivotal Trial Using Vision Preservation , Primary Outcome Measure , Proof Of Concept Study , News , Ggregator , Reaking News , Uration , Media ,